Maen Saleh
Neurology · Garden City, MINPI 1457001653
Payments from drug & device makers
Across 113 payments — averaging $37.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$632
- Neurocrine Biosciences, Inc.$402
- Teva Pharmaceuticals USA, Inc.$355
- AbbVie$344
- AstraZeneca$333
- CSL Behring$270
- plus $2K from 19 others
What the payments were for
- Food & beverage$4,254100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 17 | $632 |
| Neurocrine Biosciences, Inc. | 16 | $402 |
| Teva Pharmaceuticals USA, Inc. | 10 | $355 |
| AbbVie | 3 | $344 |
| AstraZeneca(2 entities) | 7 | $333 |
| CSL Behring | 8 | $270 |
| E.r. Squibb & Sons, L.L.C. | 3 | $265 |
| Biogen | 5 | $216 |
| Lundbeck LLC | 6 | $211 |
| Steris Corporation | 1 | $158 |
| Catalyst Pharmaceuticals, Inc. | 6 | $151 |
| Vanda Pharmaceuticals Inc. | 5 | $136 |
| Eisai Inc. | 2 | $125 |
| Pfizer | 1 | $100 |
| Livanova USA, Inc. | 2 | $95 |
| Lilly USA, LLC | 5 | $94 |
| Alnylam Pharmaceuticals Inc. | 4 | $81 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $70 |
| Otsuka America Pharmaceutical, Inc. | 2 | $50 |
| Tanabe Pharma America, Inc. | 2 | $50 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Ipsen Biopharmaceuticals, Inc | 1 | $25 |
| Jazz Pharmaceuticals Inc. | 1 | $23 |
| Argenx US, Inc. | 1 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,254 in reported general payments places this provider in the 60th percentile of 652 neurology providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Memantine Hcl | 12 | $521 |
Paid to pharmacies, not to this prescriber.
Other neurology in Garden City
- Andrew ZillgittGarden City$290K
- Aaron EllenbogenFarmington Hills$14.5M
- Martin BelkinFarmington Hills$5.8M
- Evanthia BernitsasDetroit$4.8M
- Yang Mao DraayerFarmington Hills$4.2M
- Mirela CerghetDetroit$3.8M
- Peter le WittWest Bloomfield$3.2M
- Judith HeidebrinkAnn Arbor$2.2M
- Denise LeungAnn Arbor$2M
- Rany AburashedOwosso$1.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.